Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.
Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA.
J Cell Sci. 2023 Oct 15;136(20). doi: 10.1242/jcs.261483. Epub 2023 Oct 23.
Tumor initiation at either primary or metastatic sites is an inefficient process in which tumor cells must fulfill a series of conditions. One critical condition involves the ability of individual tumor-initiating cells to overcome 'isolation stress', enabling them to survive within harsh isolating microenvironments that can feature nutrient stress, hypoxia, oxidative stress and the absence of a proper extracellular matrix (ECM). In response to isolation stress, tumor cells can exploit various adaptive strategies to develop stress tolerance and gain stemness features. In this Opinion, we discuss how strategies such as the induction of certain cell surface receptors and deposition of ECM proteins enable tumor cells to endure isolation stress, thereby gaining tumor-initiating potential. As examples, we highlight recent findings from our group demonstrating how exposure of tumor cells to isolation stress upregulates the G-protein-coupled receptor lysophosphatidic acid receptor 4 (LPAR4), its downstream target fibronectin and two fibronectin-binding integrins, α5β1 and αvβ3. These responses create a fibronectin-rich niche for tumor cells, ultimately driving stress tolerance, cancer stemness and tumor initiation. We suggest that approaches to prevent cancer cells from adapting to stress by suppressing LPAR4 induction, blocking its downstream signaling or disrupting fibronectin-integrin interactions hold promise as potential strategies for cancer treatment.
肿瘤起始于原发性或转移性部位是一个效率低下的过程,其中肿瘤细胞必须满足一系列条件。一个关键条件涉及到单个肿瘤起始细胞克服“隔离应激”的能力,使它们能够在恶劣的隔离微环境中存活,这些微环境的特点是营养应激、缺氧、氧化应激和缺乏适当的细胞外基质(ECM)。为了应对隔离应激,肿瘤细胞可以利用各种适应性策略来发展应激耐受和获得干性特征。在本观点中,我们讨论了诱导某些细胞表面受体和 ECM 蛋白沉积等策略如何使肿瘤细胞能够耐受隔离应激,从而获得肿瘤起始潜能。作为例子,我们强调了我们小组最近的发现,即肿瘤细胞暴露于隔离应激会上调 G 蛋白偶联受体溶血磷脂酸受体 4(LPAR4)、其下游靶标纤维连接蛋白以及两个纤维连接蛋白结合整联蛋白 α5β1 和 αvβ3。这些反应为肿瘤细胞创造了富含纤维连接蛋白的生态位,最终导致应激耐受、癌症干性和肿瘤起始。我们认为,通过抑制 LPAR4 的诱导、阻断其下游信号或破坏纤维连接蛋白-整联蛋白相互作用来防止肿瘤细胞适应应激的方法可能成为癌症治疗的潜在策略。